Erratum: Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection (Journal of Clinical Investigation (2004) 113 (963-972) DOI:10.1172/JCI200420515);Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

Journal of Clinical Investigation

Volumn 113, Issue 7, 2004, Pages 963-972

  Accapezzato, Daniele ^a   Francavilla, Vittorio ^a   Paroli, Marino ^a   Casciaro, Marco ^a   Chircu, Lucia Valeria ^a   Cividini, Agostino ^b   Abrignani, Sergio ^c   Mondelli, Mario U ^b   Barnaba, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c CHIRON VACCINES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 10;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; IMMUNOREACTIVITY; LIVER; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 2142702915     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420515     Document Type: Erratum

References (57)

1. Lauer, G.M., and Walker, B.D. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
2. Cooper, S., et al. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity. 10:439-449.
3. + T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur. J. Immunol. 31:894-906.
4. + T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl. Acad. Sci. U. S. A. 96:5692-5697.
5. Lechner, F., et al. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499-1512.
6. Thimme, R., et al. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:1395-1406.
7. Gruener, N.H., et al. 2001. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75:5550-5558.
8. Urbani, S., et al. 2002. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 76:12423-12434.
9. Scognamiglio, P., et al. 1999. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J. Immunol. 162:6681-6689.
10. Francavilla, V., et al. 2004. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms. Eur. J. Immunol. 34:427-437.
11. Accapezzato, D., et al. 2004. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: the role of the virus. Eur. J. Immunol. 34:438-446.
12. Moskophidis, D., Lechner, F., Pircher, H., and Zinkernagel, R.M. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 362:758-761.
13. Zajac, A.J., et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
14. Wedemeyer, H., et al. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169:3447-3458.
15. Champagne, P., et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 410:106-111.
16. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379-385.
17. Grabowska, A.M., et al. 2001. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur. J. Immunol. 31:2388-2394.
18. Maloy, K.J., and Powrie, F. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816-822.
19. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 101:455-458.
20. Shevach, E.M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
21. Hori, S., Nomura, T., and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
22. Lider, O., Reshef, T., Beraud, E., Ben-Nun, A., and Cohen, I.R. 1988. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science. 239:181-183.
23. Gaur, A., Ruberti, G., Haspel, R., Mayer, J.P., and Fathman, C.G. 1993. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. Science. 259:91-94.
24. -/- mice. Science. 256:1210-1213.
25. Sallusto, F., Lenig, D., Forster, R., Lipp, M., and Lanzavecchia, A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:708-712.
26. Desmet, V.J., Gerber, M., Hoofnagle, J.H., Manns, M., and Scheuer, P.J. 1994. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1513-1520.
27. Sallusto, F., and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med 179:1109-1118.
28. Propato, A., et al. 2001. Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat. Med. 7:807-813.
29. Barnaba, V., et al. 1989. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J. Immunol. 143:2650-2655.
30. Sprent, J., and Surh, C.D. 2002. T cell memory. Annu. Rev. Immunol. 20:551-579.
31. Wherry, E.J., et al. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234.
32. Gett, A.V., Sallusto, F., Lanzavecchia, A., and Geginat, J. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4:355-360.
33. + T lymphocyte responses. Nat. Immunol. 4:361-365.
34. Manjunath, N., et al. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108:871-878.
35. + T cells. J. Exp. Med. 194:953-966.
36. Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T., and Jenkins, M.K. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 410:101-105.
37. Masopust, D., Vezys, V., Marzo, A.L., and Lefrancois, L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 291:2413-2417.
38. + regulatory T cells control Leishmania major persistence and immunity. Nature. 420:502-507.
39. Pradat, P., et al. 2002. Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology. 36:973-977.
40. Guidotti, L.G., and Chisari, F.V. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8:478-483.
41. Gilliet, M., and Liu, Y.J. 2002. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195:695-704.
42. + T-cell subset inhibits andgen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
43. McGuirk, P., McCann, C., and Mills, K.H. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-231.
44. Sing, A., et al. 2002. Yersinia V-antigen exploits +toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196:1017-1024.
45. Pasare, C., and Medzhitov, R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
46. Paroli, M., et al. 2002. Long-lasting memory-resting and memory-effector CD4+ T cells in human X-linked agammaglobulinemia. Blood. 99:2131-2137.
47. s cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:237-243.
48. Barnaba, V., Franco, A., Alberti, A., Benvenuto, R., and Balsano, F. 1990. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature. 345:258-260.
49. Franco, A., et al. 1992. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J. Exp. Med. 175:1195-1205.
50. Trambas, C.M., and Griffiths, G.M. 2003. Delivering the kiss of death. Nat. Immunol. 4:399-403.
51. Planz, O., Seiler, P., Hengartner, H., and Zinkernagel, R.M. 1996. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies. Nature. 382:726-729.
52. Farci, P., et al. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 288:339-344.
53. Erickson, A.L., et al. 2001. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity. 15:883-895.
54. Kittlesen, D.J., Chianese-Bullick, K.A., Yao, Z.Q., Braciale, T.J., and Hahn, Y.S. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106:1239-1249.
55. Yao, Z.Q., Nguyen, D.T., Hiotellis, A.I., and Hahn, Y.S. 2001. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167:5264-5272.
56. Crotta, S., et al. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195:35-42.
57. + T cells after infection. Nat. Immunol. 3:619-626.